we are

54% of UK cancer deaths are from rare and less common cancers.

Despite this, these cancers remain severely under represented and

under-funded across all areas, including policy, services and research.

Cancer52 is an alliance of nearly 100 organisations working to address this inequality and improve outcomes for patients with these highly challenging diseases.

of diagnoses are for rare and less common cancers

of deaths are

from rare and less common cancers

why are diagnosis and death stats so different?

We work on matters that impact on the

rare and less common cancer community.

These are our objectives:

Unify and empower our member organisations.

Use our unique structure to capture the patient voice of those with rare and less common cancers.

Take that voice on to those bodies and individuals who influence cancer policy, science, clinical outputs, services and treatment.

@Cancer52org

Our Recent News

Cancer52 in the New Statesman

We are delighted that Cancer52 features in this month's New Statesman's Oncology Supplement, published to coincide with this year's Britain Against Cancer conference.

The supplement features articles f...

Cancer52 film on PHE website

In June, at the PHE Cancer Services, Data and Outcomes Conference 2018, Cancer52 worked with the National Cancer Registration and Analysis Service (NCRAS), part of PHE, to highlight the importance of...

Please reload